|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute of Mental Health (NIMH) |
|---|---|
| Information provided by: | National Institute of Mental Health (NIMH) |
| ClinicalTrials.gov Identifier: | NCT00073671 |
Purpose
This study examines the impact of a group cognitive behavioral program aimed at preventing depressive disorders and symptoms in adolescents at risk for developing depression.
| Condition | Intervention |
|---|---|
|
Depression |
Behavioral: Cognitive-behavioral prevention program Other: Usual care |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | Prevention of Depression in At-Risk Adolescents |
| Enrollment: | 316 |
| Study Start Date: | March 2003 |
| Estimated Study Completion Date: | January 2009 |
| Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
Participants receive a group cognitive-behavioral prevention program
|
Behavioral: Cognitive-behavioral prevention program
Cognitive-behavioral prevention program includes 8 weekly and 6 monthly group sessions.
|
|
2: Active Comparator
Participants receive usual care
|
Other: Usual care
Participants receive usual care
|
Depression is a prevalent, chronic, and impairing condition that is often undetected and becomes more difficult to treat as chronicity increases. There is an increasing need to conduct large-scale depression prevention studies in adolescents. This study evaluates a cognitive-behavioral prevention (CBP) program to determine its effectiveness in preventing depressive disorders in at-risk adolescents. The study also will ascertain the costs this intervention to inform attempts at future dissemination of the program in "real world" settings.
Participants in this study are randomly assigned to receive either CBP for eight weekly and 6 monthly continuation sessions or usual care. Depressive symptoms and disorders, levels of functioning, and medical and mental health care utilization are assessed at baseline and again at 2, 8, 20, and 32 months after intake.
Eligibility| Ages Eligible for Study: | 13 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations| United States, Massachusetts | |
| Harvard University Medical School | |
| Boston, Massachusetts, United States, 02115-5794 | |
| United States, Oregon | |
| Kaiser Permanente Center for Health Research | |
| Portland, Oregon, United States, 97227 | |
| United States, Pennsylvania | |
| University of Pittsburgh Medical Center | |
| Pittsburgh, Pennsylvania, United States, 15213-2593 | |
| United States, Tennessee | |
| Vanderbilt University | |
| Nashville, Tennessee, United States, 37203-5721 | |
| Principal Investigator: | Judy Garber, PhD | Vanderbilt University |
More Information
| Responsible Party: | Vanderbilt University ( Judy Garber ) |
| Study ID Numbers: | R01 MH64735, DSIR 84-CTP |
| Study First Received: | December 2, 2003 |
| Last Updated: | September 22, 2008 |
| ClinicalTrials.gov Identifier: | NCT00073671 History of Changes |
| Health Authority: | United States: Federal Government |
|
Adolescent |
|
Depression Mental Disorders Mood Disorders Depressive Disorder Behavioral Symptoms |